HI
MRNA icon

Hoey Investments’s Moderna MRNA Stock Holding History

Hoey Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,363
Closed -$141K – 367
2023
Q3 		$141K Buy
1,363
+277
+26% +$30.9K 0.05% 90
2023
Q2 		$132K Sell
1,086
-450
-29% -$60K 0.04% 98
2023
Q1 		$236K Sell
1,536
-400
-21% -$66K 0.09% 80
2022
Q4 		$348K Sell
1,936
-450
-19% -$73.6K 0.15% 72
2022
Q3 		$282K Buy
2,386
+1,250
+110% +$190K 0.11% 77
2022
Q2 		$162K Sell
1,136
-64
-5% -$9.15K 0.07% 78
2022
Q1 		$207K Buy
1,200
+414
+53% +$69.7K 0.06% 69
2021
Q4 		$200K Sell
786
-17,009
-96% -$4.97M 0.05% 62
2021
Q3 		$6.85M Buy
17,795
+4,903
+38% +$1.81M 2.05% 12
2021
Q2 		$3.03M Buy
12,892
+12,672
+5,760% +$2.26M 0.9% 22
2021
Q1 		$29K Buy
220
+200
+1,000% +$29K 0.01% 132
2020
Q4 		$2K Sell
20
-20
-50% -$2.02K ﹤0.01% 171
2020
Q3 		$3K Hold
40
– – ﹤0.01% 126
2020
Q2 		$3K Buy
+40
New +$2.19K ﹤0.01% 131

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hoey Investments's MRNA Position: Q4 2023 in Review

Hoey Investments sold out of Moderna (MRNA) in Q4 2023, closing a stake of 1,363 shares — an estimated $141K sold.

Hoey Investments first reported a position in MRNA in Q2 2020 and held it in 14 quarters. The position peaked at $6.85M in Q3 2021. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Hoey Investments reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Hoey Investments sold 1,363 Moderna shares in Q4 2023, an estimated $141K.
  • Hoey Investments first reported a position in Moderna in Q2 2020 and held it in 14 quarters.
  • Hoey Investments's Moderna position peaked at $6.85M in Q3 2021.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Hoey Investments's 13F filing for Q4 2023, filed 13 Feb 2024.